On January 27, 2026, ICON plc, a global leader in clinical research, officially inaugurated the Brian Moran Cancer Institute at Duly Health and Care in Illinois. This expansion significantly strengthens the oncology research capabilities of the Accellacare Site Network and broadens access to experimental cancer treatments for patients throughout the Chicago suburbs.
The new institute is named in memory of the late Dr. Brian J. Moran, a visionary leader in radiation oncology and prostate cancer care. The facility operates under an integrated multidisciplinary model, featuring a robust team of specialists:
-
14 Medical Oncologists: Focused on advanced systemic therapies.
-
3 Radiation Oncologists: Leading precision radiation treatments.
-
9 Fellowship-trained Surgical Specialists: Experts in urologic, breast, colorectal, endocrine, and general surgical oncology.
The establishment of the Brian Moran Cancer Institute builds upon Accellacare’s established oncology expertise in Iowa. It directly addresses patient recruitment, which remains one of the most critical hurdles in oncology clinical development. By partnering with Duly Health and Care, ICON aims to expand its investigator base and create a flagship site that accelerates the delivery of next-generation cancer therapies to the community.
Source: https://www.contractpharma.com/breaking-news/icon-opens-new-cancer-institute-in-illinois/